- Home
- ORKA vs HONE Comparison
ORKA vs HONE Comparison
Compare ORKA & HONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- HONE
- Stock Information
- Founded
- ORKA 2004
- HONE 1917
- Country
- ORKA United States
- HONE United States
- Employees
- ORKA N/A
- HONE N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- HONE Major Banks
- Sector
- ORKA Health Care
- HONE Finance
- Exchange
- ORKA Nasdaq
- HONE Nasdaq
- Market Cap
- ORKA 580.3M
- HONE 547.7M
- IPO Year
- ORKA N/A
- HONE 2016
- Fundamental
- Price
- ORKA $15.57
- HONE $13.08
- Analyst Decision
- ORKA Strong Buy
- HONE Buy
- Analyst Count
- ORKA 8
- HONE 3
- Target Price
- ORKA $40.43
- HONE $14.50
- AVG Volume (30 Days)
- ORKA 137.1K
- HONE 193.6K
- Earning Date
- ORKA 08-11-2025
- HONE 10-23-2025
- Dividend Yield
- ORKA N/A
- HONE 2.82%
- EPS Growth
- ORKA N/A
- HONE 71.76
- EPS
- ORKA N/A
- HONE 0.65
- Revenue
- ORKA N/A
- HONE $164,819,000.00
- Revenue This Year
- ORKA N/A
- HONE N/A
- Revenue Next Year
- ORKA N/A
- HONE $14.24
- P/E Ratio
- ORKA N/A
- HONE $19.66
- Revenue Growth
- ORKA N/A
- HONE N/A
- 52 Week Low
- ORKA $5.49
- HONE $8.89
- 52 Week High
- ORKA $31.13
- HONE $13.73
- Technical
- Relative Strength Index (RSI)
- ORKA 53.65
- HONE 64.46
- Support Level
- ORKA $15.52
- HONE $12.69
- Resistance Level
- ORKA $16.21
- HONE $13.10
- Average True Range (ATR)
- ORKA 0.90
- HONE 0.27
- MACD
- ORKA 0.01
- HONE 0.01
- Stochastic Oscillator
- ORKA 48.43
- HONE 86.45
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About HONE HarborOne Bancorp Inc.
HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in Boston, Massachusetts, and Providence, Rhode Island.